Douglas M. Evans

Dose dependency and wound healing aspects of the use of tissue plasminogen activator in the prevention of intra-abdominal adhesions

Douglas M. Evans, Kevin McAree, Daniel P. Guyton et al. · The American Journal of Surgery · 1993 · 100 citations

Tissue Engineering, Scar Management, Wound Healing Aspects +10

Time and dose dependency of the suppression of pulmonary metastases of rat mammary cancer by amiloride

Douglas M. Evans, Kimberly D. Sloan-Stakleff, Michael E. Arvan et al. · Clinical & Experimental Metastasis · 1998 · 40 citations

Suppression of the Invasive Capacity of Human Breast Cancer Cells by Inhibition of Urokinase Plasminogen Activator via Amiloride and B428

Douglas M. Evans, Kimberly D. Sloan-Stakleff · The American Surgeon · 2000 · 25 citations

Invasive Capacity, Matrigel Invasion Chambers, Urokinase Plasminogen Activator +15

Suppression of pulmonary metastases of rat mammary cancer by recombinant urokinase plasminogen activator inhibitor.

Douglas M. Evans, Pan Lin · PubMed · 1995 · 24 citations

Cell Surface-bound Plasmin, Pathology, Cancer Biology +19

Control of pulmonary metastases of rat mammary cancer by inhibition of uPA and COX-2, singly and in combination

Douglas M. Evans, K. D. Sloan Stakleff · Clinical & Experimental Metastasis · 2004 · 23 citations

Rat Mammary Cancer, Medicine, Pulmonary Metastases +11